Carodyl 100 Tablet

Overview Carodyl 100 Tablet

Carprofen, marketed as Carodyl 100 Tablet, belongs to the propionic acid class of non-steroidal anti-inflammatory drugs (NSAIDs), a group that also encompasses ibuprofen, naproxen, and ketoprofen. Its chemical name is 6-chloro-α-methyl-9H-carbazole-2-acetic acid, a substituted carbazole derivative.

Primary Ingredients of Carodyl 100 Tablet

Rimadyl

Major Benefits of Carodyl 100 Tablet:

• Carodyl is used to alleviate pain and inflammation in dogs with osteoarthritis, and to manage postoperative pain following soft tissue and orthopedic procedures.
• Carprofen, a non-steroidal anti-inflammatory drug (NSAID), possesses analgesic and antipyretic properties comparable to indomethacin in animal studies; it is not a narcotic.
• Studies demonstrate that carprofen suppresses the production of various prostaglandins within two types of inflammatory cells: rat polymorphonuclear leukocytes and human rheumatoid synovial cells. This suggests carprofen's ability to mitigate both acute (PMN-mediated) and chronic (synovial cell-mediated) inflammation.

How to Use Carodyl 100 Tablet:

Administer Carodyl chewable tablets to dogs orally at a rate of 2 mg per pound of body weight daily. This can be given as a single 2 mg/lb dose or split into two 1 mg/lb doses. For managing post-surgical pain, give the medication roughly two hours prior to the procedure. Carodyl tablets are scored for easy division; adjust dosages in half-tablet increments by gently breaking the tablet along the score line. These palatable tablets are readily accepted by most dogs and can be hand-fed or mixed with food. Always confirm the dog has ingested the entire prescribed dose.

Safety Instruction of Carodyl 100 Tablet:

• Administer orally to canines exclusively.
• Canine patients with a history of adverse reactions to carprofen should not receive Carodyl.
• Store where children cannot access.
• For veterinary or laboratory use only.
• Seek medical advice if accidental human consumption occurs.
• Administer to canines exclusively; contraindicated in felines.
• Prior to starting non-steroidal anti-inflammatory drugs, a complete medical history and physical assessment is mandatory for every canine patient.
• Pre-treatment and regular monitoring of hematological and serum biochemistry profiles with appropriate laboratory testing should be considered before and throughout the use of any nonsteroidal anti-inflammatory drug.
• Caregivers should monitor for indications of possible adverse drug reactions.
• Exclusively for veterinary professionals, veterinary hospitals, laboratories, or agricultural settings.